BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9535035)

  • 1. Flow cytometry using annexin V can detect early apoptosis in peripheral blood stem cell harvests from patients with leukaemia and lymphoma.
    Anthony RS; McKelvie ND; Cunningham AJ; Craig JI; Rogers SY; Parker AC
    Bone Marrow Transplant; 1998 Mar; 21(5):441-6. PubMed ID: 9535035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dielectrophoresis enrichment of CD34+ cells from peripheral blood stem cell harvests.
    Stephens M; Talary MS; Pethig R; Burnett AK; Mills KI
    Bone Marrow Transplant; 1996 Oct; 18(4):777-82. PubMed ID: 8899194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants.
    Schuurhuis GJ; Muijen MM; Oberink JW; de Boer F; Ossenkoppele GJ; Broxterman HJ
    Bone Marrow Transplant; 2001 Mar; 27(5):487-98. PubMed ID: 11313682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A contribution to a study of apoptosis of hematopoietic stem cells CD34+ by flow cytometry before and after cryopreservation].
    Ben Nasr M; Jenhani F
    Transfus Clin Biol; 2008 Jun; 15(3):91-7. PubMed ID: 18619889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases.
    Abrahamsen JF; Bakken AM; Bruserud Ø; Gjertsen BT
    Bone Marrow Transplant; 2002 Jan; 29(2):165-71. PubMed ID: 11850712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
    Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
    Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
    Leung W; Chen AR; Klann RC; Moss TJ; Davis JM; Noga SJ; Cohen KJ; Friedman AD; Small D; Schwartz CL; Borowitz MJ; Wharam MD; Paidas CN; Long CA; Karandish S; McMannis JD; Kastan MB; Civin CI
    Bone Marrow Transplant; 1998 Nov; 22(10):971-9. PubMed ID: 9849694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling technique.
    Span LF; Pennings AH; Vierwinden G; Boezeman JB; Raymakers RA; de Witte T
    Cytometry; 2002 Jan; 47(1):24-31. PubMed ID: 11774346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
    Watts MJ; Ings SJ; Leverett D; MacMillan A; Devereux S; Goldstone AH; Linch DC
    Br J Cancer; 2000 Jan; 82(2):278-82. PubMed ID: 10646877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new four-color flow cytometric assay to detect apoptosis in lymphocyte subsets of cultured peripheral blood cells.
    Hasper HJ; Weghorst RM; Richel DJ; Meerwaldt JH; Olthuis FM; Schenkeveld CE
    Cytometry; 2000 Jun; 40(2):167-71. PubMed ID: 10805937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic volume of CD34 positive cells from peripheral blood apheresis samples.
    Shariatmadar S; Sharma S; Cabana R; Powell S; Ruiz P; Krishan A
    Cytometry B Clin Cytom; 2008 May; 74(3):182-8. PubMed ID: 18383271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
    McQuaker I; Haynes A; Stainer C; Byrne J; Russell N
    Bone Marrow Transplant; 1999 Oct; 24(7):715-22. PubMed ID: 10516673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen.
    Dawson MA; Schwarer AP; Muirhead JL; Bailey MJ; Bollard GM; Spencer A
    Bone Marrow Transplant; 2005 Sep; 36(5):389-96. PubMed ID: 15980882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.